ACADIA Pharmaceuticals Inc. (ACAD) Lifted to "Hold" at ValuEngine

ACADIA Pharmaceuticals Inc. (ACAD) Lifted to

ACADIA Pharmaceuticals has an average rating of Buy and an average price target of $43.23. Moving out to look at the previous month volatility move, the stock is at 1.94%.

Several research analysts have issued reports on the stock. Wedbush maintained the stock with "Outperform" rating in Friday, July 29 report. Piper Jaffray has "Neutral" rating and $48.0 target. Massmutual Fsb Adv has invested 0% in ACADIA Pharmaceuticals Inc. Vetr has "Hold" rating and $51.38 target.

08/08/2016 - ACADIA Pharmaceuticals Inc. had its "buy" rating reiterated by analysts at JMP Securities. Fincl Architects has invested 0.01% in ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals had 22 analyst reports since August 7, 2015 according to SRatingsIntel. (NASDAQ:ACAD) Performing Well? As per Friday, April 28, the company rating was maintained by Maxim Group. The stock of ACADIA Pharmaceuticals Inc. Venbio Select Advisor LLC claims 614,200 shares with a value of $17,130,000. The value of the investment in ACAD increased from $94,668,000 to $117,539,000 a change of 24.2% since the last quarter. Acadia Pharmaceuticals now has $4.32B valuation. ACAD has diverse figures for different time frames; starting from week's performance it has positive performance of 5.26% in last five regular trading sessions. About 14 shares traded.

Investors sentiment decreased to 1.05 in Q4 2016. Its down 0.06, from 1.11 in 2016Q3. 119.51 million shares or 2.68% more from 116.39 million shares in 2016Q3 were reported. Fred Alger Mngmt reported 0.31% of its portfolio in ACADIA Pharmaceuticals Inc.

Separately, Executive Vice President Glenn Baity unloaded 38,097 stocks of the company's shares in a trade that took place on Thurs, Jul 20th. Da Davidson & Company holds 0% or 630 shares in its portfolio. Blackrock Invest Mngmt Limited Liability Corporation owns 0% invested in ACADIA Pharmaceuticals Inc. It also reduced Celgene Corp (NASDAQ:CELG) stake by 48,137 shares and now owns 433,981 shares. Employees Retirement Association Of Colorado owns 21,405 shares. Manufacturers Life Insur The holds 0% or 10,597 shares. (NASDAQ:ACAD)'s near-term growth potential.

11/11/2016 - Goldman Sachs began new coverage on ACADIA Pharmaceuticals Inc. giving the company a "neutral" rating. (NASDAQ:ACAD). Hightower Advsr invested in 0% or 9,196 shares.

08/05/2016 - ACADIA Pharmaceuticals Inc. was downgraded to "hold" by analysts at Aegis Capital. (NASDAQ:ACAD) for 36,171 shares. (NASDAQ:ACAD). Lpl Limited Liability Corporation invested in 23,705 shares.

ACADIA Pharmaceuticals Inc., launched on January 16, 1997, is a biopharmaceutical company. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.36 billion. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. It now has negative earnings. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis).

The stock increased 1.54% or $0.55 on September 1, reaching $36.16.

Recently analysts working for various investment brokerages have changed their ratings and price targets on shares of ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since September 5, 2016 and is downtrending. It has underperformed by 31.89% the S&P500. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. Therefore 63% are positive. The firm has "Buy" rating by Jefferies given on Thursday, July 27. The rating was maintained by Needham on Monday, June 19 with "Sell". RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. The firm has "Market Perform" rating given on Tuesday, May 3 by Leerink Swann. Oppenheimer has "Hold" rating and $14800 target. Sterne Agee CRT initiated the shares of SYK in report on Wednesday, November 4 with "Neutral" rating. The shares were purchased at an average price of $30.00. The insider Scannell Timothy J sold 13,322 shares worth $1.81M. With 1,900 avg volume, 0 days are for Servotronics Incorporated (NYSEMKT:SVT)'s short sellers to cover SVT's short positions.

Investors sentiment decreased to 0.85 in Q4 2016. It dropped, as 50 investors sold SYK shares while 331 reduced holdings. 26 funds opened positions while 74 raised stakes. 318,832 shares or 2.73% more from 310,364 shares in 2016Q3 were reported. Ingalls And Snyder Lc invested 0.02% in Spectra Energy Partners, LP (NYSE:SEP). Sandy Spring National Bank & Trust, a Maryland-based fund reported 1,500 shares. Morgan Stanley has 0% invested in Servotronics, Inc. State Of New Jersey Common Pension Fund D reported 85,900 shares stake. Parametrica Management accumulated 18,223 shares. It also upped Novartis (NYSE:NVS) stake by 34,314 shares and now owns 67,214 shares. State Of Wisconsin Investment Board holds 55,226 shares.

Like this



07 September 2017
Carl Frampton confirms Jamie Moore as new trainer after split from McGuigans
Today Frampton confirmed that Moore, who has worked with Tommy Coyle and Matthew Macklin, would take over training duites. Frampton has not yet unveiled who will be his new promoter after ditching Barry McGuigan's Cyclone Promotions.

07 September 2017
HD Supply Holdings, Inc. (NASDAQ:HDS) Traded Above Its 50 Day Average
The stock of HD Supply Holdings Inc (NASDAQ:HDS) has "Outperform" rating given on Wednesday, December 7 by RBC Capital Markets. RBC Capital Markets downgraded the shares of HDS in report on Tuesday, September 20 to "Sector Perform" rating.

07 September 2017
Cognizant Technology Solutions Corporation (NASDAQ:CTSH) COO Srinivasan Veeraraghavachary Sells 2500 Shares
On August 8 the stock rating was upgraded from "Buy" to "Buy" and a price target of $85.00 was set by analysts at Berenberg. Moreover, Ancora Advisors Lc has 0.14% invested in Cognizant Technology Solutions Corp (NASDAQ:CTSH) for 34,760 shares.

07 September 2017
Supreme Court asks government for detailed reply on deportation of Rohingyas
That also applies equally to Rohingyas who have settled in different parts of the country, including Jammu and Kashmir. Rijiju said that India will not use force for deportation, rather will follow legal procedures.

07 September 2017
Samsung's OLED Monopoly Blamed for Higher iPhone 8 Price Tag
UBS makes the somewhat questionable argument that Apple starts with a price and then develops a product to hit that budget. The iPhone has always set the benchmark for other manufacturers to try and come up with even better features.

07 September 2017
Teleflex Inc (NYSE:TFX) Q4 2016 Sentiment
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. The stock has a market capitalization of $9.50 billion, a price-to-earnings ratio of 40.34 and a beta of 1.05.

07 September 2017
Diego Waits to Find Out the Costa His Antics
Exhausted of reading? Click through the gallery above to see the 12 highest paid stars at the Blues, according to the Daily Star. Chelsea have been fining Costa fortnightly while he has been in Brazil.

07 September 2017
Which Insiders Are Selling Eli Lilly and Company (LLY)?
This company shares are 11.79% off its target price of $89.52 and the current market capitalization stands at $87.3B. Brown & Brown, a diversified insurance agency, wholesale brokerage, insurance programs and service company.

07 September 2017
Special Counsel Mueller Clashes With Senate Intel Committee
Erin Pelton, a spokeswoman for Rice, said she had met voluntarily with the committee as part of its investigation. Anything Trump, Jr says in the Senate meeting can be used against him and it is a crime to lie to Congress.

07 September 2017
Genworth Financial (GNW) Receives Coverage Optimism Rating of 0.19
Finally, BidaskClub upgraded Genworth Financial from a "sell" rating to a "hold" rating in a research note on Tuesday, June 13th. The highest price GNW stock touched in the last 12 month was $5.27 and the lowest price it hit in the same period was $3.23.